SPDR S&P Pharmaceuticals ETF
Price through Oct 27, 2026 · Flows through Oct 26, 2026. Figures use the latest available records, not a live quote. Fund details retrieved Oct 27, 2026. Holdings snapshot retrieved Oct 27, 2026.
In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI").
XPH price
Table
| Date | XPH close |
|---|---|
| Sep 28, 2026 | $66.89 |
| Sep 29, 2026 | $66.09 |
| Sep 30, 2026 | $65.00 |
| Oct 1, 2026 | $63.78 |
| Oct 2, 2026 | $63.64 |
| Oct 5, 2026 | $63.66 |
| Oct 6, 2026 | $62.91 |
| Oct 7, 2026 | $62.91 |
| Oct 8, 2026 | $63.63 |
| Oct 9, 2026 | $64.65 |
| Oct 12, 2026 | $64.01 |
| Oct 13, 2026 | $62.10 |
| Oct 14, 2026 | $62.07 |
| Oct 15, 2026 | $63.02 |
| Oct 16, 2026 | $61.84 |
| Oct 19, 2026 | $62.24 |
| Oct 20, 2026 | $64.15 |
| Oct 21, 2026 | $63.96 |
| Oct 22, 2026 | $64.28 |
| Oct 23, 2026 | $62.70 |
| Oct 26, 2026 | $62.90 |
| Oct 27, 2026 | $63.96 |
Daily net flows, 1M
Net outflow over the range: −$80M
- Inflow / above zero
- Outflow / below zero
Show as table
| Label | Value ($) |
|---|---|
| Sep 28 | −$6.6M |
| Sep 29 | $0 |
| Sep 30 | −$6.6M |
| Oct 1 | −$3.2M |
| Oct 2 | −$22.4M |
| Oct 5 | $0 |
| Oct 6 | −$18.9M |
| Oct 7 | −$9.4M |
| Oct 8 | $3.1M |
| Oct 9 | $0 |
| Oct 12 | −$3.2M |
| Oct 13 | $0 |
| Oct 14 | −$3.1M |
| Oct 15 | $0 |
| Oct 16 | $0 |
| Oct 19 | −$6.2M |
| Oct 20 | $0 |
| Oct 21 | $0 |
| Oct 22 | −$3.2M |
| Oct 23 | $0 |
| Oct 26 | $0 |
Money is leaving — −$80M in net outflows over the past month, about 18.1% of the fund's asset base, while the price has returned +14.2% so far this year. At 0.35% a year it is not the cheapest way in — IWM has a reported fee of 0.19%.
COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH
CELL SIZE IS PORTFOLIO WEIGHT · COLOR IS THE CHANGE IN THE LATEST AVAILABLE SNAPSHOT · TOP 40 POSITIONS
| # | Holding | Weight | Price | Day | 52-wk | |
|---|---|---|---|---|---|---|
| 1 | AMLXAMYLYX PHARMACEUTICALS | 2.04% | $28.30 | +4.5% | ||
| 2 | OMEROMEROS | 1.42% | $17.49 | +7.4% | ||
| 3 | MBXMBX Biosciences | 2.72% | $52.97 | +5.3% | ||
| 4 | DFTXDefinium Therapeutics | 3.09% | $37.08 | +3.9% | ||
| 5 | PCRXPACIRA BIOSCIENCES | 1.65% | $36.40 | +0.1% | ||
| 6 | MANEVERADERMICS INC | 2.02% | $140.72 | +2.4% | ||
| 7 | PRGOPERRIGO CO | 1.42% | $16.02 | +1.3% | ||
| 8 | AMRXAMNEAL PHARMACEUTICALS | 1.72% | $21.44 | +2.0% | ||
| 9 | MAZEMaze Therapeutics | 1.85% | $31.69 | +2.0% | ||
| 10 | LGNDLIGAND PHARMACEUTICALS | 1.94% | $311.73 | +1.1% | ||
| 11 | ETONETON PHARMACEUTICALS | 1.30% | $51.16 | +2.0% | ||
| 12 | XERSXERIS BIOPHARMA HOLDINGS | 1.39% | $10.45 | +2.4% | ||
| 13 | EWTXEDGEWISE THERAPEUTICS | 1.88% | $39.53 | +0.9% | ||
| 14 | RPRXROYALTY PHARMA | 1.57% | $65.28 | +0.8% | ||
| 15 | MRKMERCK & CO | 1.65% | $141.82 | +0.9% |
The full book, free with one sign-in.
Top 15 positions are open to everyone. Sign in once and every fund’s complete holdings — plus watchlists and flow alerts — unlock across the network.
Sign in to see all 41Sector weights
- Healthcare100%
- Health Technology99.68%
- Other0.33%
- Mutual fund0.32%
Show as table
| Item | Value (%) |
|---|---|
| Healthcare | 100% |
| Health Technology | 99.68% |
| Other | 0.33% |
| Mutual fund | 0.32% |
Country weights
- United States99.6%
- Ireland9.31%
- Singapore0.4%
- Cayman Islands0.39%
Show as table
| Item | Value (%) |
|---|---|
| United States | 99.6% |
| Ireland | 9.31% |
| Singapore | 0.4% |
| Cayman Islands | 0.39% |
| 1 week | 0.0% |
| 1 month | -3.2% |
| 3 months | -6.7% |
| 6 months | +11.4% |
| YTD | +14.2% |
| 1 year | +30.2% |
| 3 years | — |
PRICE RETURN, DISTRIBUTIONS NOT REINVESTED
| 1 week | −$3M |
| 1 month | −$80M |
| 3 months | +$11M |
| YTD | +$186M |
| 1 year | +$206M |
CREATION/REDEMPTION DOLLARS, DAILY RECORDS
Monthly net flows
- Inflow / above zero
- Outflow / below zero
Show as table
| Label | Value ($) |
|---|---|
| Nov | $5.3M |
| Dec | $14.8M |
| Jan | $61.6M |
| Feb | $28.4M |
| Mar | $0 |
| Apr | $25.3M |
| May | −$5.5M |
| Jun | $27.4M |
| Jul | $51.5M |
| Aug | $78.7M |
| Sep | −$15.3M |
| Oct | −$66.5M |
The top holding is 3.1% of the book; the top ten carry 22%. Spread across 66+ names, it behaves like roughly 60 equally-weighted positions.
VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK
| Most-traded holdings, options premium | Bullish | Bearish |
|---|---|---|
| LLY ELI LILLY | $24M | $26M |
| MRK MERCK & CO | $3M | $4M |
| JNJ JOHNSON & JOHNSON | $4M | $3M |
| LQDA LIQUIDIA | $2M | $3M |
| PFE PFIZER | $2M | $2M |
TODAY’S OPTIONS PREMIUM IN THE FUND’S UNDERLYING NAMES
Due diligence cuts both ways. These funds sit on the same shelf and beat XPH on at least one dimension that matters — the fee, the asset base, or where the money is going.
| Fund | Fee | Assets | Flow, 1M | The case | |
|---|---|---|---|---|---|
| SPDW SPDR Portfolio Developed World ex-US ETF | 0.03% | $40.7B | +$609M | -32bp on fee · 92× the assets · +$609M in over the month | Head-to-head |
| SPMD State Street SPDR Portfolio S&P 400 Mid Cap ETF | 0.03% | $18.4B | +$199M | -32bp on fee · 42× the assets · +$199M in over the month | Head-to-head |
| IDEV iShares Core MSCI International Developed Markets ETF | 0.04% | $32.4B | +$497M | -31bp on fee · 74× the assets · +$497M in over the month | Head-to-head |
| IGSB iShares 1-5 Year Investment Grade Corporate Bond ETF | 0.04% | $23.7B | +$47M | -31bp on fee · 54× the assets · +$47M in over the month | Head-to-head |
| IGIB iShares 5-10 Year Investment Grade Corporate Bond ETF | 0.04% | $18.6B | +$412M | -31bp on fee · 42× the assets · +$412M in over the month | Head-to-head |